Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Bronchial neuroendocrine neoplasias comprise a wide spectrum of well-differentiated tumors (typical/atypical carcinoids) to undifferentiated carcinomas such as small (SCLC) and large cell (LC) neuroendocrine carcinomas with a fatal prognosis. Therapeutic options are unsatisfactory.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Lewens F
Authors: Lewens F, Freitag H, Briest F, Heilmann M, Schneider C,
Keywords: bronchial, NETs, PI3K, FoxM1, survivin, cell lines, SCLC,
#29 Serum chromogranin A correlation with tumor burden in metastatic small bowel carcinoid patients
Introduction: Patients with neuroendocrine tumors may have clinical courses that range from fairly indolent to more aggressive. Cross–sectional studies, nuclear imaging and biochemical markers are often used to monitor disease progression. Optimal surveillance tests and intervals have not been firmly established. Studies suggest that chromogranin A (CgA) may be a surrogate marker for tumor burden.
Conference: 7th Annual ENETSConcerence (2010)
Presenting Author: Curran T
Authors: Schneiderman M, Curran T, Lee K, Warner R, Kim M,
Keywords: carcinoid, metastatic, biomarkers, radiology, chromogranin A,
Introduction: Neuroendocrine tumors demonstrate heterogeneous behavior based upon site of origin and specific histology. Even after controlling for anatomic location, disease stage and histologic grade, registry studies show persistent diversity of outcome in patients with midgut carcinoid.
Conference: 7th Annual ENETSConcerence (2010)
Presenting Author:
Authors: Curran T, Serbowicz S, Patel K, Schneiderman M, Ward S,
Keywords: carcinoid. small bowel, metastatic, chromogranin-A,